 |
 |
Hi all, As more Parkinson's treatments involving surgery move into phase II clinical trials, (such as CERE120 and GAD gene therapies and Spheramine cell therapy), we can expect increased use of sham surgery in clinical trial designs. As a placebo control, sham surgery means there will be some patients that will undergo anesthesia, IV solutions, and surgical prep to undergo anesthesia, will have to be placed on IV solutions, and be surgically prepped, but will not receive the treatment under trial. No one other than the neurosurgeon will know who receives the sham surgery. What is your view of the use of sham brain surgery in Parkinson’s research? To read more about sham surgery and reply to short survey being conducted by the Parkinson Pipeline Project-- go to www.pdpipeline.org and click on "Survey on Sham Surgery" (under What's New. ) Responses can be anonymous, if you prefer. Thank you. We appreciate your opinions. Linda Herman www.pdpipeline.org ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn